Ayoglu Burcu, Szarka Eszter, Huber Krisztina, Orosz Anita, Babos Fruzsina, Magyar Anna, Hudecz Ferenc, Rojkovich Bernadette, Gáti Tamás, Nagy György, Schwenk Jochen M, Sármay Gabriella, Prechl József, Nilsson Peter, Papp Krisztián
Affinity Proteomics, SciLifeLab, School of Biotechnology, KTH Royal Institute of Technology, Stockholm, Sweden.
Department of Immunology, Eötvös Loránd University, Budapest, Hungary.
PLoS One. 2014 May 5;9(5):e96403. doi: 10.1371/journal.pone.0096403. eCollection 2014.
The development of antigen arrays has provided researchers with great tools to identify reactivities against self or foreign antigens from body fluids. Yet, these approaches mostly do not address antibody isotypes and their effector functions even though these are key points for a more detailed understanding of disease processes. Here, we present a bead array-based assay for a multiplexed determination of antigen-specific antibody levels in parallel with their properties for complement activation. We measured the deposition of C3 fragments from serum samples to reflect the degree of complement activation via all three complement activation pathways. We utilized the assay on a bead array containing native and citrullinated peptide antigens to investigate the levels of IgG, IgM and IgA autoantibodies along with their complement activating properties in serum samples of 41 rheumatoid arthritis patients and 40 controls. Our analysis revealed significantly higher IgG reactivity against the citrullinated fibrinogen β and filaggrin peptides as well as an IgA reactivity that was exclusive for citrullinated fibrinogen β peptide and C3 deposition in rheumatoid arthritis patients. In addition, we characterized the humoral immune response against the viral EBNA-1 antigen to demonstrate the applicability of this assay beyond autoimmune conditions. We observed that particular buffer compositions were demanded for separate measurement of antibody reactivity and complement activation, as detection of antigen-antibody complexes appeared to be masked due to C3 deposition. We also found that rheumatoid factors of IgM isotype altered C3 deposition and introduced false-positive reactivities against EBNA-1 antigen. In conclusion, the presented bead-based assay setup can be utilized to profile antibody reactivities and immune-complex induced complement activation in a high-throughput manner and could facilitate the understanding and diagnosis of several diseases where complement activation plays role in the pathomechanism.
抗原芯片的发展为研究人员提供了强大的工具,用于从体液中鉴定针对自身或外来抗原的反应性。然而,尽管这些要点对于更详细地了解疾病过程至关重要,但这些方法大多未涉及抗体亚型及其效应功能。在此,我们展示了一种基于微珠阵列的检测方法,用于多重测定抗原特异性抗体水平及其补体激活特性。我们测量了血清样本中C3片段的沉积,以反映通过所有三种补体激活途径的补体激活程度。我们在包含天然和瓜氨酸化肽抗原的微珠阵列上使用该检测方法,研究了41例类风湿性关节炎患者和40例对照的血清样本中IgG、IgM和IgA自身抗体的水平及其补体激活特性。我们的分析显示,类风湿性关节炎患者中针对瓜氨酸化纤维蛋白原β和丝聚蛋白肽的IgG反应性显著更高,以及仅针对瓜氨酸化纤维蛋白原β肽和C3沉积的IgA反应性。此外,我们对针对病毒EBNA-1抗原的体液免疫反应进行了表征,以证明该检测方法在自身免疫性疾病之外的适用性。我们观察到,分别测量抗体反应性和补体激活需要特定的缓冲液组成,因为由于C3沉积,抗原-抗体复合物的检测似乎被掩盖了。我们还发现,IgM亚型的类风湿因子改变了C3沉积,并引入了针对EBNA-1抗原的假阳性反应性。总之,所展示的基于微珠的检测设置可用于以高通量方式分析抗体反应性和免疫复合物诱导的补体激活,并有助于理解和诊断几种补体激活在发病机制中起作用的疾病。